Terms: = Gastric cancer AND P2RY8, RP11-261P4_4, 286530, ENSG00000182162, MGC50878, P2Y8, Q86VZ1 AND Treatment
9938 results:
1. Real-world safety and effectiveness of anamorelin for cancer cachexia: Interim analysis of post-marketing surveillance in Japan.
Takayama K; Kojima A; Honda C; Nakayama M; Kanemata S; Endo T; Muro K
Cancer Med; 2024 May; 13(9):e7170. PubMed ID: 38693813
[TBL] [Abstract] [Full Text] [Related]
2. Clinical impact of skeletal muscle mass change during the neoadjuvant chemotherapy period in patients with gastric cancer: An ancillary study of JCOG1002.
Sato R; Tokunaga M; Mizusawa J; Sato Y; Ito S; Takahari D; Sano T; Onaya H; Yoshikawa T; Boku N; Terashima M
World J Surg; 2024 Jan; 48(1):163-174. PubMed ID: 38686798
[TBL] [Abstract] [Full Text] [Related]
3. Risk factors associated with lymph node metastasis in early-stage distal gastric cancer.
Yu Z; Liang C; Li R; Gao J; Gao Y; Zhou S; Li P
World J Surg; 2024 Jan; 48(1):151-162. PubMed ID: 38686759
[TBL] [Abstract] [Full Text] [Related]
4. EBV-Associated gastric cancer; An In Situ Hybridization Assay on Tissue Microarray: A Multi-Region Study from Four Major Provinces of Iran.
Abolhasani M; Mohseni AO; Shakeri R; Khavanin A; Khajehei M; Omidi A; Geramizadeh B; Shafigh E; Naghshvar F; Fathizadeh P; Taghizadehgan L; Gharib A; Gulley ML; Dawsey SM; Malekzadeh R; Rabkin CS; Vasei M
Arch Iran Med; 2024 Apr; 27(4):191-199. PubMed ID: 38685845
[TBL] [Abstract] [Full Text] [Related]
5. The Clinical Impact of the Prognostic Immune and Nutritional Index in gastric cancer Patients Who Received Curative treatment.
Aoyama T; Hashimoto I; Maezawa Y; Hara K; Tamagawa A; Cho H; Morita J; Tanabe M; Numata M; Kawahara S; Oshima T; Saito A; Yukawa N
Anticancer Res; 2024 May; 44(5):2231-2238. PubMed ID: 38677750
[TBL] [Abstract] [Full Text] [Related]
6. The Important Role of GPX1 and NF-κB Signaling Pathway in Human gastric cancer: Implications for Cell Proliferation and Invasion.
Jang BI; Jung JY; Koh SA; Lee KH
Cancer Genomics Proteomics; 2024 Apr; 21(3):305-315. PubMed ID: 38670589
[TBL] [Abstract] [Full Text] [Related]
7. Creatinine-to-cystatin C ratio and body composition predict response to PD-1 inhibitors-based combination treatment in metastatic gastric cancer.
Ji H; Liu B; Jin P; Li Y; Cui L; Jin S; Wu J; Shan Y; Zhang Z; Ming J; Zhang L; Du C
Front Immunol; 2024; 15():1364728. PubMed ID: 38665913
[TBL] [Abstract] [Full Text] [Related]
8. Efficacy and safety of biosimilar trastuzumab (CT-P6) in routine clinical practice in the Republic of Korea: a real-world post-marketing surveillance study.
Park MH; Seo JH; Park JH; Seong MK; Park KU; Kim MK; Chang M; Koh SJ; Lee MH; Lim ST; Yoo YB; Oh SY; Kim SH; Ahn KY; Park TH; Ju H; Baek EH; Kim S; Kim N; Lee E; Kim TH
Expert Opin Biol Ther; 2024 Apr; 24(4):305-312. PubMed ID: 38664937
[TBL] [Abstract] [Full Text] [Related]
9. Microbiome signatures associated with clinical stages of gastric cancer: whole metagenome shotgun sequencing study.
Jeong S; Liao YT; Tsai MH; Wang YK; Wu IC; Liu CJ; Wu MS; Chan TS; Chen MY; Hu PJ; Kao WY; Liu HC; Tsai MJ; Liu CY; Chang CC; Wu DC; Hsu YH
BMC Microbiol; 2024 Apr; 24(1):139. PubMed ID: 38658841
[TBL] [Abstract] [Full Text] [Related]
10. [A Case of Advanced gastric cancer Treated with Conversion Surgery followed by Nivolumab Combination Chemotherapy].
Sekino N; Natsume T; Tanaka H; Kainuma O; Sato Y; Note H; Yoshioka T; Kamata T; Odera H; Uchiyama M; Maruyama T; Takahashi H; Hirano S
Gan To Kagaku Ryoho; 2024 Apr; 51(4):417-420. PubMed ID: 38644309
[TBL] [Abstract] [Full Text] [Related]
11. [The efficacy and safety of laparoscopic radical gastrectomy after neoadjuvant chemotherapy combined with immunotherapy and targeted therapy].
Shao XX; Li WK; Hu HT; Lu YM; Jiang YJ; Tian YT
Zhonghua Yi Xue Za Zhi; 2024 Apr; 104(16):1397-1402. PubMed ID: 38644290
[No Abstract] [Full Text] [Related]
12. [Therapeutic efficacy analysis of endoscopic combined with serological diagnosis strategy and endoscopic in G1 and G2 gastric neuroendocrine neoplasms].
Li WY; Liu Y; Zhang YM; Dou LZ; He S; Ke Y; Liu XD; Liu YM; Wu HR; Wang GQ
Zhonghua Zhong Liu Za Zhi; 2024 Apr; 46(4):326-334. PubMed ID: 38644268
[No Abstract] [Full Text] [Related]
13. [Enhancing survival outcomes in stage Ⅲ gastric/esophagogastric junction cancer: a retrospective study of immune checkpoint inhibitors and adjuvant chemotherapy based on real-world data].
Yang XQ; Rao Z; Wei HK; Xue ZC; Liu HY; Duan QF; Sun XW; Wang W
Zhonghua Wei Chang Wai Ke Za Zhi; 2024 Apr; 27(4):395-402. PubMed ID: 38644245
[No Abstract] [Full Text] [Related]
14. Over-the-scope clip as a rescue treatment for massive bleeding due to Dieulafoy lesion at the colorectal anastomosis: A case report.
Han P; Li D; Guo Q; Lei Y; Liu J; Tian D; Yan W
Medicine (Baltimore); 2024 Apr; 103(16):e37871. PubMed ID: 38640308
[TBL] [Abstract] [Full Text] [Related]
15. Successful treatment of gastric cancer 10 years after heart transplantation: A case report.
Zhao L; Wang Y; Guo Z
Medicine (Baltimore); 2024 Apr; 103(16):e37841. PubMed ID: 38640302
[TBL] [Abstract] [Full Text] [Related]
16. Development and validation of a nomogram to predict cancer-specific survival of elderly patients with unresected gastric cancer who received chemotherapy.
Wang Q; Shen K; Fei B; Wei M; Ge X; Xie Z
Sci Rep; 2024 Apr; 14(1):9008. PubMed ID: 38637579
[TBL] [Abstract] [Full Text] [Related]
17. Phase I/II clinical trial of efficacy and safety of EGCG oxygen nebulization inhalation in the treatment of COVID-19 pneumonia patients with cancer.
Yin X; Zhu W; Tang X; Yang G; Zhao X; Zhao K; Jiang L; Li X; Zhao H; Wang X; Yan Y; Xing L; Yu J; Meng X; Zhao H
BMC Cancer; 2024 Apr; 24(1):486. PubMed ID: 38632501
[TBL] [Abstract] [Full Text] [Related]
18. Amlodipine inhibits Synaptotagmin-4's oncogenic activity on gastric cancer proliferation by targeting calcium signaling.
Huang W; Yang S; Deng M; Luo R; Liang H; Shen Y; Yang B; Xu C; Hou Y
Funct Integr Genomics; 2024 Apr; 24(3):77. PubMed ID: 38632140
[TBL] [Abstract] [Full Text] [Related]
19. Real-world evidence of treatment patterns and survival of metastatic gastric cancer patients in Germany.
Luna J; Picker N; Wilke T; Lutz M; Hess J; Mörtl B; Xiong Y; Götze TO
BMC Cancer; 2024 Apr; 24(1):462. PubMed ID: 38614966
[TBL] [Abstract] [Full Text] [Related]
20. A Phase I Study of KIN-3248, an Irreversible Small-molecule Pan-FGFR Inhibitor, in Patients with Advanced FGFR2/3-driven Solid Tumors.
Garmezy B; Borad MJ; Bahleda R; Perez CA; Chen LT; Kato S; Oh DY; Severson P; Tam BY; Quah CS; Harding JJ
Cancer Res Commun; 2024 Apr; 4(4):1165-1173. PubMed ID: 38602417
[TBL] [Abstract] [Full Text] [Related]
[Next]